Literature DB >> 15814473

Interaction between surgical procedure for repairing retinal detachment and clinical risk factors for proliferative vitreoretinopathy.

E Rodriguez de la Rúa1, J C Pastor, J Aragón, A Mayo-Iscar, V Martínez, J García-Arumí, A Giraldo, M R Sanabria-Ruiz Colmenares, I Miranda.   

Abstract

PURPOSE: To asses risk factors of proliferative vitreoretinopathy (PVR) and a model for predicting it.
METHODS: Observational, case-control. 335 patients with non-complicated retinal detachment (RD) were included: 134 developed PVR (Cases); 201 patients did not (Controls). Risk factors for PVR were identified by multivariate analysis. Influence of variables was assayed according to the surgical approach. By logistic regression analysis a model to predict the risk of developing PVR and odds ratio (OR) values for each clinical factor were estimated.
RESULTS: Risk was higher in patients > 70 years and with intraocular pressure lower than 14 (OR: 3.84; CI 95%: 2.04-7.30) and in retinal breaks larger than "1 clock hour" (OR: 2.54; CI: 1.28-5.05), extended retinal detachments (OR: 4.01; CI: 1.98-8.10) and reinterventions (OR: 1.55; CI: 1.14-9.22). Scleral surgery also was a risk factor (OR: 3.89; CI: 2.12-7.14) and aphakia/pseudophakia when scleral surgery is performed (OR: 3.33; CI: 1.54-7.22). A model to predict PVR was proposed with these results.
CONCLUSIONS: Surgical approach modifies risk factors of PVR, and should be taken into account to improve the models for predicting it.

Entities:  

Mesh:

Year:  2005        PMID: 15814473     DOI: 10.1080/02713680490904142

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  9 in total

Review 1.  Proliferative Vitreoretinopathy: A Review.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2019

2.  A novel function of p53: a gatekeeper of retinal detachment.

Authors:  Hetian Lei; Marc-Andre Rheaume; Jing Cui; Shizuo Mukai; David Maberley; Arif Samad; Joanne Matsubara; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2012-09       Impact factor: 4.307

3.  Pars plana vitrectomy for primary rhegmatogenous retinal detachment.

Authors:  Stephen G Schwartz; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2008-03

4.  The Vitrectomy Timing Individualization System for Ocular Trauma (VTISOT).

Authors:  Longhui Han; Jinchen Jia; Yiming Fan; Luyong Yang; Zhiqiang Yue; Wei Zhang; Fang Liu; Huanjun Kang; Tao Huo; Shaolei Han; Hua Shen; Genquan Tian; Xuemin Su
Journal:  Sci Rep       Date:  2019-08-30       Impact factor: 4.379

5.  Rhegmatogenous Retinal Detachment with a High Risk of Proliferative Vitreoretinopathy Treated with Episcleral Surgery and an Intravitreal Dexamethasone 0.7-mg Implant.

Authors:  Michele Reibaldi; Andrea Russo; Antonio Longo; Vincenza Bonfiglio; Maurizio G Uva; Caterina Gagliano; Mario D Toro; Teresio Avitabile
Journal:  Case Rep Ophthalmol       Date:  2013-04-24

6.  Transcriptional regulatory network analysis during epithelial-mesenchymal transformation of retinal pigment epithelium.

Authors:  Craig H Pratt; Rajanikanth Vadigepalli; Praveen Chakravarthula; Gregory E Gonye; Nancy J Philp; Gerald B Grunwald
Journal:  Mol Vis       Date:  2008-08-04       Impact factor: 2.367

7.  Loss of Visual Acuity after Successful Surgery for Macula-On Rhegmatogenous Retinal Detachment in a Prospective Multicentre Study.

Authors:  Salvatore Di Lauro; Melissa Castrejón; Itziar Fernández; Jimena Rojas; Rosa M Coco; María R Sanabria; Enrique Rodríguez de la Rua; J Carlos Pastor
Journal:  J Ophthalmol       Date:  2015-11-12       Impact factor: 1.909

8.  Variations in Functional and Anatomical Outcomes and in Proliferative Vitreoretinopathy Rate along a Prospective Collaborative Study on Primary Rhegmatogenous Retinal Detachments: The Retina 1 Project-Report 4.

Authors:  J Carlos Pastor; Itziar Fernández; Rosa M Coco; María R Sanabria; Enrique Rodríguez de la Rúa; Rosa M Piñon; Vicente Martinez; Anna Sala-Puigdollers; José M Gallardo; Sara Velilla
Journal:  ISRN Ophthalmol       Date:  2012-10-08

9.  The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.

Authors:  Salvador Pastor-Idoate; Irene Rodríguez-Hernández; Jimena Rojas; Itziar Fernández; María T García-Gutiérrez; José M Ruiz-Moreno; Amandio Rocha-Sousa; Yashin Ramkissoon; Steven Harsum; Robert E MacLaren; David Charteris; Jan C VanMeurs; Rogelio González-Sarmiento; José C Pastor
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.